BR0114813A - Soluções farmacêuticas de compostos de modafinila e seu uso - Google Patents
Soluções farmacêuticas de compostos de modafinila e seu usoInfo
- Publication number
- BR0114813A BR0114813A BR0114813-3A BR0114813A BR0114813A BR 0114813 A BR0114813 A BR 0114813A BR 0114813 A BR0114813 A BR 0114813A BR 0114813 A BR0114813 A BR 0114813A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical solutions
- modafinil compound
- compound pharmaceutical
- modafinil
- compounds
- Prior art date
Links
- 239000003186 pharmaceutical solution Substances 0.000 title abstract 2
- -1 Modafinil compound Chemical class 0.000 title 1
- 229960001165 modafinil Drugs 0.000 title 1
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical group C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
"SOLUçõES FARMACêUTICAS DE COMPOSTOS DE MODAFINILA E SEU USO". Composições farmacêuticas de compostos de modafinila, e composições farmacêuticas, não-aquosas de compostos de modafinila em solventes orgânicos são descritas, ao longo desta solução com seu uso no tratamento de doenças.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23948800P | 2000-10-11 | 2000-10-11 | |
US09/974,473 US6489363B2 (en) | 2000-10-11 | 2001-10-10 | Pharmaceutical solutions of modafinil compounds |
PCT/US2001/031685 WO2002030413A1 (en) | 2000-10-11 | 2001-10-11 | Pharmaceutical solutions of modafinil compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0114813A true BR0114813A (pt) | 2005-01-25 |
Family
ID=26932612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0114813-3A BR0114813A (pt) | 2000-10-11 | 2001-10-11 | Soluções farmacêuticas de compostos de modafinila e seu uso |
Country Status (22)
Country | Link |
---|---|
US (1) | US6489363B2 (pt) |
EP (1) | EP1324755B1 (pt) |
JP (1) | JP2004510816A (pt) |
KR (1) | KR100846914B1 (pt) |
CN (1) | CN100518726C (pt) |
AT (1) | ATE478662T1 (pt) |
AU (2) | AU2001296785B2 (pt) |
BG (1) | BG66221B1 (pt) |
BR (1) | BR0114813A (pt) |
CA (1) | CA2425218C (pt) |
CZ (1) | CZ2003966A3 (pt) |
DE (1) | DE60142913D1 (pt) |
EA (1) | EA005572B1 (pt) |
HK (1) | HK1057336A1 (pt) |
HU (1) | HU229424B1 (pt) |
IL (2) | IL155263A0 (pt) |
MX (1) | MXPA03003150A (pt) |
NO (1) | NO333096B1 (pt) |
NZ (1) | NZ525166A (pt) |
PL (1) | PL214879B1 (pt) |
SK (1) | SK287436B6 (pt) |
WO (1) | WO2002030413A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU229409B1 (en) * | 2000-10-11 | 2013-12-30 | Cephalon | Compositions comprising modafinil compounds |
US6919378B2 (en) * | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
FR2849029B1 (fr) * | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
DK1610796T3 (da) * | 2003-03-17 | 2014-07-21 | Neurohealing Pharmaceuticals Inc | Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade |
US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
US8153159B2 (en) * | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
BRPI0500520A (pt) * | 2005-02-16 | 2006-09-26 | Henry Jun Suzuki | uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas |
WO2007013962A2 (en) * | 2005-07-21 | 2007-02-01 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
DK2056811T3 (en) * | 2006-08-14 | 2018-05-22 | Neurohealing Pharmaceuticals Inc | Modafinil-based treatment for premature ejaculation |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
CA2629979A1 (en) * | 2008-04-25 | 2009-10-25 | Pharmascience Inc. | Novel resveratrol compositions |
FR2987265B1 (fr) | 2012-02-28 | 2014-02-28 | Debregeas Et Associes Pharma | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
FR2987266B1 (fr) | 2012-02-28 | 2014-12-19 | Debregeas Et Associes Pharma | Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application |
SG11201503051QA (en) * | 2012-10-18 | 2015-05-28 | Abbvie Inc | Formulations of pyrimidinedione derivative compounds |
US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1584462A (en) | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
FR2663225B1 (fr) | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
FR2771004B1 (fr) | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US20010034373A1 (en) | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
-
2001
- 2001-10-10 US US09/974,473 patent/US6489363B2/en not_active Expired - Lifetime
- 2001-10-11 EA EA200300450A patent/EA005572B1/ru not_active IP Right Cessation
- 2001-10-11 WO PCT/US2001/031685 patent/WO2002030413A1/en active Application Filing
- 2001-10-11 MX MXPA03003150A patent/MXPA03003150A/es active IP Right Grant
- 2001-10-11 PL PL361134A patent/PL214879B1/pl unknown
- 2001-10-11 DE DE60142913T patent/DE60142913D1/de not_active Expired - Lifetime
- 2001-10-11 AU AU2001296785A patent/AU2001296785B2/en not_active Ceased
- 2001-10-11 AU AU9678501A patent/AU9678501A/xx active Pending
- 2001-10-11 CA CA2425218A patent/CA2425218C/en not_active Expired - Fee Related
- 2001-10-11 HU HU0302478A patent/HU229424B1/hu not_active IP Right Cessation
- 2001-10-11 AT AT01977685T patent/ATE478662T1/de not_active IP Right Cessation
- 2001-10-11 CN CNB018171273A patent/CN100518726C/zh not_active Expired - Fee Related
- 2001-10-11 NZ NZ525166A patent/NZ525166A/en not_active IP Right Cessation
- 2001-10-11 SK SK440-2003A patent/SK287436B6/sk not_active IP Right Cessation
- 2001-10-11 JP JP2002533856A patent/JP2004510816A/ja active Pending
- 2001-10-11 CZ CZ2003966A patent/CZ2003966A3/cs unknown
- 2001-10-11 KR KR1020037005057A patent/KR100846914B1/ko not_active IP Right Cessation
- 2001-10-11 IL IL15526301A patent/IL155263A0/xx active IP Right Review Request
- 2001-10-11 EP EP01977685A patent/EP1324755B1/en not_active Expired - Lifetime
- 2001-10-11 BR BR0114813-3A patent/BR0114813A/pt active Search and Examination
-
2003
- 2003-04-06 IL IL155263A patent/IL155263A/en not_active IP Right Cessation
- 2003-04-10 NO NO20031648A patent/NO333096B1/no not_active IP Right Cessation
- 2003-04-14 BG BG107720A patent/BG66221B1/bg unknown
-
2004
- 2004-01-09 HK HK04100157.5A patent/HK1057336A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0114813A (pt) | Soluções farmacêuticas de compostos de modafinila e seu uso | |
EA200000594A1 (ru) | Новые макролиды | |
EA200200571A1 (ru) | Новая композиция и ее применение | |
EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
DK0778731T3 (da) | Ionenpolymerer indeholdende biologisk aktive anioner | |
EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
EA200000789A1 (ru) | N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии | |
EA200100623A1 (ru) | Кетолидные антибиотики | |
EA200400432A1 (ru) | Производные мочевины | |
BRPI9810519A (pt) | derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
EA200100315A1 (ru) | Простые тетрагидропиридовые эфиры | |
EA199900749A1 (ru) | Фармацевтическая композиция | |
DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
EA200201214A1 (ru) | Замещенные тиоацетамиды | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
BR0116698A (pt) | Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos | |
EA200400701A1 (ru) | 13-членные азалиды и их применение в качестве антибиотических агентов | |
BR9707247A (pt) | Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios | |
EA200400530A1 (ru) | Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин" | |
AR012217A1 (es) | Una composicion topica para mejorar la penetracion de compuestos farmaceuticos | |
BR9611343A (pt) | Processo de solubilização d eum agente em um anfifìlico, composição, e, uso da mesma. | |
SE0003476D0 (sv) | Compounds | |
BR9816029A (pt) | Composições detergente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 15A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |